Latest:
Advanced Cholangiocarcinoma: Molecular Testing
Experts who treat patients with GI cancers, such as cholangiocarcinoma, emphasize the need for more standardized approaches to molecular testing.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
John L. Marshall, MD, MedStar Georgetown University Hospital
Latest:
Novel Approaches Under Study for Metastatic CRC
John L. Marshall, MD; Marwan G. Fakih, MD; and Joleen M. Hubbard, MD, highlight novel strategies in the metastatic colorectal cancer pipeline that look exciting and consider their integration into future clinical practice.
John M. Burke, MD
John M. Burke, MD, is a hematologist and medical oncologist at Rocky Mountain Cancer Centers
Latest:
Dr Burke on CLL Treatment Challenges in Community vs Academic Health Care Settings
John M. Burke, MD, discusses the challenges associated with using venetoclax for CLL management across both community and academic oncology settings.
John M. Pagel, MD, PhD, Swedish Cancer Institute
Latest:
Delivering Long-Term Results for Blood Cancer Patients
While great progress has been made in developing and delivering new treatment options for chronic lymphocytic leukemia, recognizing the chronic nature of the disease and being cognizant of side effects that can have a major impact on a patient’s quality of life remains an important responsibility.
John Marshall, MD, Georgetown University Lombardi Comprehensive Cancer Center
Latest:
Metastatic Colorectal Cancer: Ongoing Challenges and Future Directions in Care
Closing out their panel on metastatic colorectal cancer, expert oncologists consider ongoing challenges and future evolutions within the treatment landscape.